- Motley Fool•18 hours ago
Carl Icahn has reportedly bought shares in this big-cap biopharma, but Bristol-Myers Squibb might be too big and costly to win an acquirer.
- Motley Fool•22 hours ago
Array BioPharma has been a huge winner in recent months. Can this biotech stock go much higher?
- Investopedia•2 days ago
Roche’s Alecensa adds the large EU market for non-small cell lung cancer treatment.
RHHBY : Summary for ROCHE HLDG LTD SPONS - Yahoo Finance
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.38 - 30.55|
|52 Week Range||25.25 - 33.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.75|
|Dividend & Yield||1.02 (3.32%)|
|1y Target Est||N/A|